The Neonatal Narcotic Withdrawal Index: A Device for the Improvement of Care in the Abstinence Syndrome

Green, Marvin; Suffet, Frederic

doi:10.3109/00952998108999125

Cited by 72 publications

(26 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…102 This more comprehensive instrument assigns a cumulative score based on the interval observation of 21 items relating to signs of neonatal withdrawal. 103 In 1 study, administration of this scoring system with infants verified not to have been exposed to prenatal opiates by meconium analysis resulted in a stable median score of 2 during each of the first 3 days of life, with 95th percentile scores of 5.5 and 7 on days 1 and 2, respectively.…”

Section: Assessment and Nonpharmacologic Treatmentmentioning

confidence: 99%

Neonatal Drug Withdrawal

Hudak¹,

Tan²,

Frattarelli³

et al. 2012

Pediatrics

758

608

View full text Add to dashboard Cite

Maternal use of certain drugs during pregnancy can result in transient neonatal signs consistent with withdrawal or acute toxicity or cause sustained signs consistent with a lasting drug effect. In addition, hospitalized infants who are treated with opioids or benzodiazepines to provide analgesia or sedation may be at risk for manifesting signs of withdrawal. This statement updates information about the clinical presentation of infants exposed to intrauterine drugs and the therapeutic options for treatment of withdrawal and is expanded to include evidence-based approaches to the management of the hospitalized infant who requires weaning from analgesics or sedatives.

show abstract

Section: Assessment and Nonpharmacologic Treatmentmentioning

confidence: 99%

Neonatal Drug Withdrawal

Hudak¹,

Tan²,

Frattarelli³

et al. 2012

Pediatrics

758

608

View full text Add to dashboard Cite

show abstract

“…Due to the aforementioned reasons the scientists have tried to find a brief and easier method for determining the requirement for treatment in neonates with NAS, therefore many scoring systems were proposed; neonatal drug withdrawal scoring system (NDWSS) (also known as the Lipsitz Scale) (12), the Ostrea tool (13), neonatal narcotic withdrawal index (NNWI) (14), the neonatal withdrawal inventory (NWI) (15), the withdrawal assessment tool (WAT-1), opioid and benzodiazepine withdrawal scale (OBWS) (16), and the brief 3-item screening index (17), are among the proposed screening tools.…”

Section: Introductionmentioning

confidence: 99%

Treating Neonatal Abstinence Syndrome from Clinical Perspectives

et al. 2017

View full text Add to dashboard Cite

Background: The Finnegan scoring system which is used to initiate and guide neonatal abstinence syndrome (NAS) therapy has several limitations that make it difficult to be used by many healthcare providers. Therefore in practice many experienced clinicians use their clinical judgements for initiating and continuation of NAS treatment. Objectives: Assessing the degree of association between clinical judgments of experienced neonatologists and the Finnegan scoring system to initiate NAS treatment, and identifying the most prevalent items of the Finnegan scoring system which are independently associated with the need for NAS treatment. Methods: This multi-centric prospective cohort study evaluated 60 admitted neonates who were born to illicit drugs dependent mothers and exhibited signs and symptoms of NAS. Neonates were evaluated based on the Finnegan scoring system once at birth

show abstract

“…14 A review of NAS research literature reveals a common objective shared by early tool developers: the need for a short and simple clinical tool. 15,16 Several published tools share common elements for scoring signs and symptoms of abstinence syndrome; however, there is variation in documented reliability and validity of the tools. Some tool developers adapted items from previously published tools in the creation of a shorter tool.…”

Section: Overview Of Clinical Assessment Toolsmentioning

confidence: 99%

An Overview of Clinical Tools Used to Assess Neonatal Abstinence Syndrome

Orlando

2014

Journal of Perinatal &Amp; Neonatal Nursing

View full text Add to dashboard Cite

Several clinical tools have been developed to quantify the severity of withdrawal signs and symptoms exhibited by infants born to substance-using mothers. Scores from the systematic assessments are used to guide treatment of infants with moderate to severe clinical signs. This article provides an overview of published assessment tools developed for infants with neonatal abstinence syndrome. Nurses caring for infants at risk for neonatal abstinence syndrome should be knowledgeable about the tools used to evaluate these infants and guide their treatment. The ideal assessment tool should be published and include item definitions and a protocol for administering the tool. Nurses need education and training to achieve competency and interobserver reliability in the use of a selected tool. Tool-specific materials should be used to standardize training and improve accuracy in assessments. Competent and knowledgeable nurses play a critical role in improving outcomes for infants with neonatal abstinence syndrome.

show abstract

The Neonatal Narcotic Withdrawal Index: A Device for the Improvement of Care in the Abstinence Syndrome

Cited by 72 publications

References 6 publications

Neonatal Drug Withdrawal

Neonatal Drug Withdrawal

Treating Neonatal Abstinence Syndrome from Clinical Perspectives

An Overview of Clinical Tools Used to Assess Neonatal Abstinence Syndrome

Contact Info

Product

Resources

About